- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01871948
Effective Communication for Preventing and Responding to Oncology Adverse Events (CanComm)
12 décembre 2013 mis à jour par: Kathleen Mazor, University of Massachusetts, Worcester
Cancer patients often experience problems in their care, many of which are caused by communication breakdowns.
Some communication breakdowns lead to adverse events and even harmful errors.
Deficiencies in provider-patient communication can compound patients' distress, lower the quality of care, and disrupt patient-provider relationships.
There is little research on patients' and providers' experiences of the communication breakdowns that precipitate adverse events and errors, or on effective responses to these events.
Because of this, cancer providers are unsure how to communicate with patients in these difficult situations.
The goal of the proposed study is to improve patient-centered communication around adverse events and errors in cancer care.
Our specific aims are: 1) To describe patients' experiences with communication around adverse events and errors in cancer care, 2) To describe providers' experiences and practices with communication around adverse events and errors in cancer care, 3) To develop practical recommendations, provider training materials and patient educational materials for improving communication around adverse events and errors in cancer care, 4) To disseminate the recommendations and materials through three health plans, and 5) To conduct a preliminary evaluation of the perceived usefulness and impact of the materials.
The investigators will first conduct interviews with breast and colorectal cancer patients who have experienced adverse events or errors at 3 Cancer Research Network (CRN) health plans (Atlanta, Georgia; Seattle, Washington and Worcester, Massachusetts).
The interviews will focus on instances where patients believe that better communication might have prevented an adverse event or error, or mitigated the event's impact.
Next the investigators will conduct focus groups to understand providers' attitudes and experiences with these communication dilemmas, and use simulations to describe providers' communication practices.
Finally, the investigators will interview health plan leaders to identify the systems factors that influence communication with patients around adverse events and errors.
These perspectives will be synthesized to create patient and provider educational material for improving communication.
Three advisory panels: a Patient Advisory Panel, a Health Plan Advisory Panel and a Dissemination Advisory Panel (including all 14 CRN health plans) will help create and disseminate these educational interventions.
Dissemination will occur at the three core clinical sites.
The investigators use patient and provider surveys to evaluate the educational materials' impact.
This evaluation will provide the evidence-base to refine the study products before widespread dissemination throughout the CRN and beyond.
The project will have the advantage of the CRN infrastructure, the CRN Clinical Communication Research Center, and is led by nationally recognized communication researchers.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Anticipé)
500
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Georgia
-
Atlanta, Georgia, États-Unis, 30305
- Kaiser Permanente Georgia
-
-
Washington
-
Seattle, Washington, États-Unis, 98124
- Group Health
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
21 ans à 80 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Cancer survivors
- 21 to 80 years of age
- Able to communicate in English
- have adequate hearing
- no cognitive impairments
Exclusion Criteria:
-Any non-melanoma skin cancer, Breast cancer in situ, Cervical intraepithelial neoplasia (CIN): types I, II, III, Stage I colon cancer, Stage IV cancer, Recurrent cancer or second primary
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Patient survey at 2 points in time
Randomly assigned patients attending cancer clinics at Washington or Georgia sites during February 2013 to August 2013 will be presented with or mailed a survey about cancer communication approximately 2 weeks later and a follow-up survey approximately 3 months later.
|
|
|
Expérimental: "WeWant to Know" campaign, patient survey at 2 time points
Randomly assigned patients attending cancer clinics at Washington or Georgia sites during February 2013 to August 2013 will be presented with or mailed a survey about cancer communication approximately 2 weeks later and a follow-up survey approximately 3 months later.
Additionally, this group will also receive a follow-up phone call approximately 4 weeks after baseline survey.
|
Randomly assigned patients attending cancer clinics at Washington or Georgia sites during February 2013 to August 2013 will be presented with or mailed a survey about cancer communication approximately 2 weeks later and a follow-up survey approximately 3 months later.
Additionally, this group will also receive a follow-up phone call approximately 4 weeks after baseline survey.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Calculate differences in satisfaction with cancer care communication, using a summary score from patient surveys, between intervention and control groups.
Délai: 8 months
|
8 months
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Kathleen M Mazor, EdD, University of Massachusetts, Worcester
- Chercheur principal: Thomas H Gallagher, MD, University of Washington
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 octobre 2008
Achèvement primaire (Réel)
1 août 2013
Achèvement de l'étude (Réel)
1 août 2013
Dates d'inscription aux études
Première soumission
22 mai 2013
Première soumission répondant aux critères de contrôle qualité
4 juin 2013
Première publication (Estimation)
7 juin 2013
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
16 décembre 2013
Dernière mise à jour soumise répondant aux critères de contrôle qualité
12 décembre 2013
Dernière vérification
1 décembre 2013
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 1184
- P20CA137219 (Subvention/contrat des NIH des États-Unis)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .